MENU

MBCOF Stock MARVEL BIOSCIENCES (MBCOF, $0.15) was the month's biggest loser, descending -10.69%

A.I.dvisor
at Tickeron.com
Loading...
MBCOF - MARVEL BIOSCIENCES CORP.
Tickeron

Loading...

Price: $0.1548
Daily change: +$0.0048 (+3.2%)
Daily volume: 49.7K
Monthly price change: -$0.01852 (-10.69%)
Capitalization: $8.1M
Industry: Biotechnology
MARVEL BIOSCIENCES (MBCOF, $0.15) was a top loser this month, diving -1 to $0.15 per share. Of the 774 stocks analyzed in the Biotechnology Industry throughout this month, of them (6) exhibited an Uptrend while of them (3) were in a Downtrend.

MBCOF in +2.22% Uptrend, rising for three consecutive days on September 30, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MBCOF advanced for three days, in of 9 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

MBCOF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MBCOF as a result. In of 26 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

MBCOF moved below its 50-day moving average on October 10, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MBCOF crossed bearishly below the 50-day moving average on October 15, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MBCOF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MBCOF entered a downward trend on October 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (23.430). P/E Ratio (0.000) is within average values for comparable stocks, (54.529). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.181). Dividend Yield (0.000) settles around the average of (0.036) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (350.392).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MBCOF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MBCOF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
MBCOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
505 - 8th Avenue SW
Phone
+1 403 770-2467
Employees
N/A
Web
https://www.marvelbiotechnology.com